Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
These results demonstrate that MBC-11 decreases bone tumor burden
enhances the phosphorylation of IκB and NF-κB (p65)
Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells
InChi: InChI=1S/C16H14O6/c17-10-3-1-9(2-4-10)7-16(21)8-22-13-6-11(18)5-12(19)14(13)15(16)20/h1-6
at concentrations up to 1 μM
CaV1.3 antagonist-1 Catalog No.:M17026-C These results demonstrate that MBC-11CaV1. 3 antagonist 1 is a potent and highly selective CaV1. 3 L type calcium channel (LTCC) antagonist with an IC50 of 1. 7 M. CaV1. 3 antagonist 1 inhibits CaV1. 3 LTCC >600 fold more potently than CaV1. 2 LTCC. CaV1. 3 antagonist 1, a cyclopentyl derivative, has the potential for Parkinson's disease research. Product information CAS Number: 1391385 57 1 Molecular Weight: 334. 80 Formula: C17H19ClN2O3 Chemical Name: 1 (3 chlorophenethyl) 3
US$ 38.00
US$ 68.00
US$ 88.00
US$ 36.00
US$ 88.00
US$ 72.00